Fathima P, Aiswarya R, Shah H, Ajithlal P, Rajesh K, Shubin C
Parasitol Res. 2024; 123(7):278.
PMID: 39023835
DOI: 10.1007/s00436-024-08304-z.
Uranw S, Bhattarai N, Cloots K, Roy L, Rai K, Kiran U
PLoS One. 2024; 19(4):e0289578.
PMID: 38630746
PMC: 11023194.
DOI: 10.1371/journal.pone.0289578.
Rocha R, Pereira A, Maia C
Pathogens. 2022; 11(8).
PMID: 36015042
PMC: 9415673.
DOI: 10.3390/pathogens11080921.
Fekri Soofi Abadi M, Moradabadi A, Vahidi R, Shojaeepour S, Rostami S, Rad I
Genes Environ. 2021; 43(1):36.
PMID: 34380574
PMC: 8356459.
DOI: 10.1186/s41021-021-00210-5.
Kobets T, cepickova M, Volkova V, Sohrabi Y, Havelkova H, Svobodova M
Front Immunol. 2019; 10:1083.
PMID: 31231359
PMC: 6566641.
DOI: 10.3389/fimmu.2019.01083.
Atypical leishmaniasis: A global perspective with emphasis on the Indian subcontinent.
Thakur L, Singh K, Shanker V, Negi A, Jain A, Matlashewski G
PLoS Negl Trop Dis. 2018; 12(9):e0006659.
PMID: 30260957
PMC: 6159859.
DOI: 10.1371/journal.pntd.0006659.
Population structures of Leishmania infantum and Leishmania tropica the causative agents of kala-azar in Southwest Iran.
Ghatee M, Mirhendi H, Karamian M, Taylor W, Sharifi I, Hosseinzadeh M
Parasitol Res. 2018; 117(11):3447-3458.
PMID: 30105405
DOI: 10.1007/s00436-018-6041-1.
Epidemiological Aspects of Visceral Leishmaniasis in Larestan and Ghiro-Karzin Counties, Southwest of Iran.
Zahra N, Davood K, Morteza A, Zahra S
Osong Public Health Res Perspect. 2018; 9(2):81-85.
PMID: 29740532
PMC: 5935142.
DOI: 10.24171/j.phrp.2018.9.2.07.
Interventions for Old World cutaneous leishmaniasis.
Heras-Mosteiro J, Monge-Maillo B, Pinart M, Lopez Pereira P, Reveiz L, Garcia-Carrasco E
Cochrane Database Syst Rev. 2017; 12:CD005067.
PMID: 29192424
PMC: 6485999.
DOI: 10.1002/14651858.CD005067.pub5.
Interventions for Old World cutaneous leishmaniasis.
Heras-Mosteiro J, Monge-Maillo B, Pinart M, Lopez Pereira P, Reveiz L, Garcia-Carrasco E
Cochrane Database Syst Rev. 2017; 11:CD005067.
PMID: 29149474
PMC: 6486265.
DOI: 10.1002/14651858.CD005067.pub4.
Effectiveness of Short-Course Meglumine Antimoniate (Glucantime®) for Treatment of Visceral Leishmaniasis: A 13-Year, Multistage, Non-Inferiority Study in Iran.
Alborzi A, Pouladfar G, Attar A, Falahi F, Jafarpour Z, Karimi A
Am J Trop Med Hyg. 2016; 96(1):182-189.
PMID: 27879460
PMC: 5239690.
DOI: 10.4269/ajtmh.16-0345.
Molecular Evaluation of a Case of Visceral Leishmaniasis Due to Leishmania tropica in Southwestern Iran.
Sarkari B, Ahmadpour N, Moshfe A, Hajjaran H
Iran J Parasitol. 2016; 11(1):126-30.
PMID: 27095980
PMC: 4835463.
Comparative study of viscerotropic pathogenicity of Leishmania major amastigotes and promastigotes based on identification of mitochondrial and nucleus sequences.
Spotin A, Parvizi P
Parasitol Res. 2015; 115(3):1221-8.
PMID: 26631188
DOI: 10.1007/s00436-015-4858-4.
Hoarseness as the Presenting Symptom of Visceral Leishmaniasis with Muco-Cutaneous Lesions: A Case Report.
Mortazavi H, Mohebali M, Taslimi Y, Sadeghipour P, Ansari M, Kamyab K
Iran J Parasitol. 2015; 10(2):296-300.
PMID: 26246830
PMC: 4522308.
Epidemiological features of visceral leishmaniasis in fars province, southern iran.
Sarkari B, Hatam G, Ghatee M
Iran J Public Health. 2012; 41(4):94-9.
PMID: 23113170
PMC: 3481615.
Leishmania major infection in humanized mice induces systemic infection and provokes a nonprotective human immune response.
Wege A, Florian C, Ernst W, Zimara N, Schleicher U, Hanses F
PLoS Negl Trop Dis. 2012; 6(7):e1741.
PMID: 22848771
PMC: 3404120.
DOI: 10.1371/journal.pntd.0001741.
Intestinal leishmaniasis in acquired immunodeficiency syndrome.
Molaei M, Minakari M, Pejhan S, Mashayekhi R, Modaress Fatthi A, Zali M
Iran Red Crescent Med J. 2012; 13(5):348-51.
PMID: 22737493
PMC: 3371974.
Leishmania major protein disulfide isomerase as a drug target: enzymatic and functional characterization.
Ben Khalaf N, De Muylder G, Louzir H, McKerrow J, Chenik M
Parasitol Res. 2011; 110(5):1911-7.
PMID: 22160278
DOI: 10.1007/s00436-011-2717-5.